A kind of leukotriene receptor antagonist, used for the prevention and long-term treatment of asthma in adults aged 15 and older, the treatment of asthmatic patients who are sensitive to aspirin and the prevention of exercise-induced bronchoconstriction.
The main content of this product is Montelukast sodium and the chemical name is [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinoline)vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl ethyl) phenyl]propyl]sulfur)methyl]cyclopropane sodium acetate.The chemical structure formula is as follows: C35H35CINNaO3S and the molecular weight is 608.17.
The prevention and long-term treatment of asthma in adults aged 15 and older, including the prevention of asthma symptoms during the day and night, the treatment of asthmatic patients who are sensitive to aspirin and the prevention of exercise-induced bronchoconstriction. This product is suitable for adults 15 years old and above to alleviate the symptoms caused by seasonal allergic rhinitis.
Oral administration.
1.Patients who are allergic to any ingredient in this product derivatives.
2.Pregnant or lactating women.